Lars Christian Lund

Medicin og biovidenskab

1. Cohort Studies 100%
2. Denmark 68%
3. Severe Acute Respiratory Syndrome 59%
4. SARS Virus 56%
5. Coronavirus 50%
6. Population 45%
7. Prescriptions 36%
8. Vaccines 35%
9. Pharmaceutical Preparations 31%
10. Confidence Intervals 30%
11. Human Influenza 28%
12. Scandinavian and Nordic Countries 25%
13. Glucagon-Like Peptide-1 Receptor 25%
14. Venous Thromboembolism 24%
15. Odds Ratio 24%
16. Mortality 22%
17. Idiopathic Pulmonary Fibrosis 22%
18. Gout 22%
19. Coronavirus Infections 21%
20. Hospitalization 21%
21. Dicloxacillin 19%
22. Incidence 19%
23. Angiotensin Receptor Antagonists 18%
24. Chronic Renal Insufficiency 17%
25. Vaccination 17%
26. Intensive Care Units 16%
27. Registries 16%
28. Safety 15%
29. Morbidity 15%
30. Serotonin Uptake Inhibitors 15%
31. Febuxostat 14%
32. Delivery of Health Care 14%
33. pimecrolimus 14%
34. Floxacillin 14%
35. Hemorrhage 14%
36. Multimorbidity 14%
37. Anti-Inflammatory Agents 14%
38. Virus Diseases 13%
39. Thioridazine 13%
40. Sodium-Glucose Transport Proteins 13%
41. Interrupted Time Series Analysis 12%
42. Pandemics 12%
43. Drug Utilization 12%
44. Lactulose 12%
45. Sweden 12%
46. Equivalence Trials 12%
47. Dipeptidyl-Peptidase IV Inhibitors 12%
48. Propensity Score 12%
49. Restless Legs Syndrome 12%